AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
6min chapter
Episode #222: The Science of Losing Fat vs. Muscle
Barbell Medicine Podcast
Terzepatide and Weight Loss
The Cermont One trial was done for 72 weeks. There seems to be this dose-dependent relationship between terzepatide and weight loss. Liraglutide is a GLP1 agonist, so a different type of medication but the same family. And they added exercise to the deal to see like, hey, can we prevent lean mass losses?
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode